[1]陈 龙,郑详武.建立一种基于BAS化学发光技术检测血清β-hCG，Prog水平的抗生物素干扰方法[J].现代检验医学杂志,2024,39(01):141-145.[doi:10.3969/j.issn.1671-7414.2024.01.026]
　CHEN Long,ZHENG Xiangwu.Establish an Anti-biotin Interference Method to Detect Serum β-hCG and Prog Levels Based on BAS Immunoassays[J].Journal of Modern Laboratory Medicine,2024,39(01):141-145.[doi:10.3969/j.issn.1671-7414.2024.01.026]
点击复制

建立一种基于BAS化学发光技术检测血清β-hCG，Prog水平的抗生物素干扰方法()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年01期
页码:
141-145
栏目:
研究简报·实验技术
出版日期:
2024-01-15

文章信息/Info

Title:
Establish an Anti-biotin Interference Method to Detect Serum β-hCG and Prog Levels Based on BAS Immunoassays
文章编号:
1671-7414（2024）01-141-05
作者:
陈 龙1; 郑详武2
（1. 通用环球西安北环医院检验科，西安 710032；2. 山阳县人民医院检验科，陕西商洛 726400）
Author(s):
CHEN Long1;  ZHENG Xiangwu2
（1.Department of Clinical Laboratory，Genertec University Xi’an Bei Huan Hospital，Xi’an 710032，China；2. Department of Clinical Laboratory，Shanyang County People’s Hospital， Shaanxi Shangluo 726400，China）
关键词:
生物素; 链霉亲和素磁珠; 人绒毛膜促性腺激素β 亚基; 孕酮
分类号:
R446
DOI:
10.3969/j.issn.1671-7414.2024.01.026
文献标志码:
A
摘要:
目的　在基于生物素- 链霉亲和素（biotin-avidin/streptavidin，BAS）的化学发光技术检测人绒毛膜促性腺激素β 亚基（β-human chorionic gonadotropin，β-hCG）和孕酮（progesterone，Prog）时，建立一种简易、有效的抗生物素干扰方法。方法　采用两种浓度链霉亲和素磁珠（streptavidin coated magnetic micro particles，M）检测不同生物素浓度的高、中、低水平的β-hCG 和Prog 血清，通过回收试验评价两种浓度M 的抗生物素干扰能力以及采用低浓度M 的校准曲线时高浓度M 检测的准确度。结果　① β-hCG 和Prog 的抗生物素干扰能力在低浓度M(0.72 mg/ml) 时分别为100 和25 ng/ml，在高浓度M(1.44 mg/ml) 时分别为500 和50 ng/ml。②使用和低浓度M 相同的校准曲线时，高浓度M对于生物素浓度在500 ng/ml 以下的β-hCG 三个水平的回收率均在90% ～ 110% 之间；对于生物素浓度在50 ng/ml 以下的高、中水平的Prog，其回收率在90% ～ 110% 之间。结论　在基于BAS 化学发光技术检测血清β-hCG 和Prog 时，采用高浓度M（1.44 mg/ml）是一种简易、有效且可靠的抗生物素干扰方法。
Abstract:
Objective　A simple and effective anti-biotin interference method was established to detect human chorionic gonadotropin β subunit (β-hCG) and progesterone (Prog) in BAS immunoassays. Methods　Using two different concentrations of streptavidin magnetic particles（M） to detect high, medium and low levels of β-hCG and Prog serum with different biotin concentrations, the anti-biotin interference ability of two kinds of M and the accuracy of high concentration M to detect β-hCG and Prog were evaluated through recovery test when the calibration curve of low concentration M is adopted. Results　① The anti-biotin interference ability of β-hCG and Prog were 100 and 25 ng/ml respectively at low concentration M(0.72 mg/ml), and were 500 and 50 ng/ml respectively at high concentration M(1.44 mg/ml) . ② When using the same calibration curve as low concentration M, the recovery rate of high concentration M for β-hCG at three levels with biotin below 500 ng/ml were between 90% and 110%，for Prog with high and medium levels of biotin below 50 ng/ml, the recovery rate were between 90% ～ 110%. Conclusion　When detecting serum nterference ability of β-hCG mmunoassays, the method of high concentration M(1.44 mg/ mL) is a simple, effective and reliable anti-biotin interference program.

参考文献/References:

[1] 国家卫生健康委临床检验中心. 临检中心数据分析[DB/OL]. [2023-05-14] http://nccl.clinet.com.cn/clinetbusiness/hospital/main1.asp.National Center for Clinical Laboratories. National center for clinical laboratories analysis of data[DB/OL].[2023-05-14]. http://nccl.clinet.com.cn/clinetbusiness/hospital/main1.asp.
[2] FDA Food and Drug Administration. Biotin (Vitamin B7): safety communication-may interfere with labtests[DB/OL].[2023-05-14].www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm586505.htm.
[3] Association for Clinical Biochemistry & Laboratory Medicine. A statement from the ACB scientific committee regarding biotin /vitamin B7 interference in immunoassays issued July 2018[OL]. http://www.acb.org.uk/docs/default-source/documents/statement-fromacb-scicom-biotin-oct2018-1.
[4] Bundesinstitut für Arzneimittel und Medizinprodukte [Federal Institute for Drugs and Medical Devices].Rote-hand-brief zu biotinhaltigen arzneimitteln: risiko falscher ergebnisse von laboruntersuchungen durch biotininterferenzen[OL]. https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RHB/2019/rhb-biotin.html.
[5] European Medicines Agency. PRAC recommendations on signals[OL]. https://www.ema.europa.eu/en/documents/prac-recommendation/pracrecommendations-signals-adopted-14-17-january-2019-prac-meeting_ en.pdf.
[6] 中华人民共和国国家卫生健康委员会. WS/T578.5-2018: 中国居民膳食营养素参考摄入量第 5 部分：水溶性维生素[S]. 北京: 中国标准出版社, 2018. National Health Commission of the People’s Republic of China. WS/T 578.5-2018: Chinese dietary reference intakes Part 5: Water-soluble vitamin[S].Beijing：Standards Press of China, 2018.
[7] ZEMPLENI J, WIJERATNE S S, HASSAN Y I. Biotin[J]. Biofactors, 2009, 35(1)：36-46.
[8] LIU Dong, GEBREAB Y B, HU Jian, et al. Development and evaluation of an anti-biotin interference method in biotin-streptavidin immunoassays[J]. Diagnostics (Basel Switzerland）, 2022, 12(7): 1729.
[9] 毕波, 吕元. 定量检测方法学性能验证的系统设计[J]. 中华检验医学杂志, 2007, 30(2): 143-145. BI Bo, L? Yuan. An appropriate design of method performance validation for quantitative tests [J].Chinese Journal of Laboratory Medicine, 2007, 30(2): 143-145.
[10] MOCK D. Biotin. In: Modern Nutrition in Health and Disease[M]. 9th ed. SHILS M (Ed), Lippincott Williams and Wilkins, 2000:459.
[11] LAZO DE LA VEGA-MONROY M L, LARRIETA E, GERMAN M S, et al. Effects of biotin supplementation in the diet on insulin secretion, islet gene expression, glucose homeostasis and beta-cell proportion[J].Journal of Nutritional Biochemistry, 2013, 24(1): 169-177.
[12] KWOK J S S, CHAN I H S, CHAN M H M. Biotin interference on TSH and free thyroid hormone measurement[J]. Pathology, 2012, 44(3): 278-280.
[13] MOSS A J, LEVY A S, KIM I, et al. Use of vitamin and mineral supplements in the United States: current users, types of products, and nutrienta[Z] . Advance Data from Vital and Health Statistics of the National Center for Health Statistics ,1989, 174：1-20
[14] BAILEY R L, GAHCHE J J, LENTINO C V, et al. Dietary supplement use in the United States, 2003-2006[J]. Journal of Nutrition, 2011, 141(2): 261-266.
[15] Institute of Medicine, A Report of the Standing Committeeonth, food and Nutrition Board: Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline[M]. Washington, DC: National Academy Press, 1998.
[16] P?HLER A, FAIGLE J, STAACK R F. Evaluation of potential biotin interference in immunogenicity testing[J]. Bioanalysis, 2019, 11(17): 1547-1554.
[17] SAMARASINGHE S, MEAH F, SINGH V, et al. Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks[J].Endocrine Practice, 2017, 23(8): 989-998.
[18] LI Jieli, WAGAR E A, MENG Q H. Comprehensive assessment of biotin interference in immunoassays[J].Clinica Chimica Acta, 2018, 487(suppl1): 293-298.
[19] 刘栋, 仝慧, 陈斌, 等. 外源性生物素对基于生物素-链霉亲和素化学发光技术干扰的研究进展[J]. 现代检验医学杂志, 2021, 36(3): 161-164. LIU Dong, TONG Hui, CHEN Bin, et al. Research progress of exogenous biotin interference on chemiluminescence immunoassay based on biotinavidin system[J]. Journal of Modern Laboratory Medicine, 2021, 36(3): 161-164.
[20] ELSTON M S, SEHGAL S, DU TOIT S, et al. Factitious graves’ disease due to biotin immunoassay Interference-A case and review of the literature[J].Journal of Clinical Endocrinology & Metabolism, 2016, 101(9): 3251-3255.
[21] PIKETTY M L, PRIE D, SEDEL F, et al. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference[J]. Clinical Chemistry and Laboratory Medicine, 2017, 55(6): 817-825.
[22] TRAMBAS C, LU Zhong, YEN T, et al. Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin-biotin immunoassays[J]. Annals of Clinical Biochemistry, 2018, 55(2): 216-226.
[23] YANG Jianbo, WIENCEK J R. Mitigating biotin interference in two Roche immunoassays by premixing biotinylated capturing molecules with streptavidin coated beads [J]. Clinica Chimica Acta, 2020, 505: 130-135.
[24] 刘栋, 仝慧, 陈斌, 等. 化学发光技术中磁珠浓度对光信号水平的影响[J]. 检验医学与临床, 2021, 18(8): 1080-1083. LIU Dong, TONG Hui, CHEN Bin, et al. Influence of magnetic bead concentration on light signal level in chemical luminescence technology[J]. Laboratory Medicine and Clinic, 2021, 18(8): 1080-1083.
[25] 佚名. 医疗机构便携式血糖检测仪管理和临床操作规范(试行)[Z]. 中华人民共和国国家卫生和计划生育委员会公报, 2011. Anonymity. Standard for management and clinical operation of portable blood glucose monitors in medical institutrons(Trial)[Z]. Bulletin of National Health Commission of the People’s Republic of China, 2011.
[26] MROSEWSKI I, URBANK M, STAUCH T, et al. Interference from high-dose biotin intake in immunoassays for potentially time-critical analytes by roche[J]. Archives of Pathology & Laboratory Medicine, 2020, 144(9): 1108-1117.

相似文献/References:

[1]郝玉萍,薛金莲,樊阳阳,等.孕妇血清生物素水平与胎儿生长及早产的相关性分析[J].现代检验医学杂志,2021,36(02):148.[doi:doi:10.3969/j.issn.1671-7414.2021.02.035]
　HAO Yu-ping,XUE Jin-lian,FAN Yang-yang,et al.Analysis of Correlation between Serum Biotin Level and Fetal Growth and Premature Delivery in Pregnant Women[J].Journal of Modern Laboratory Medicine,2021,36(01):148.[doi:doi:10.3969/j.issn.1671-7414.2021.02.035]
[2]刘　栋,张　宁,仝　慧,等.外源性生物素对基于生物素 - 链霉亲和素化学发光技术干扰的研究进展[J].现代检验医学杂志,2021,36(03):161.[doi:10.3969/j.issn.1671-7414.2021.03.038]
　LIU Dong,TONG Hui,CHEN Bin,et al.Research Progress of Exogenous Biotin Interference on ChemiluminescenceImmunoassay Based on Biotin-avidin System[J].Journal of Modern Laboratory Medicine,2021,36(01):161.[doi:10.3969/j.issn.1671-7414.2021.03.038]
[3]谭玉华,于 婷,余海枷,等.基于生物素 亲和素时间分辨荧光免疫法检测血清可溶性fms样酪氨酸激酶-1的方法建立及性能评价[J].现代检验医学杂志,2025,40(02):186.[doi:10.3969/j.issn.1671-7414.2025.02.035]
　TAN Yuhua,YU Ting,YU Haijia,et al.Establishment and Performance Evaluation of Method for Detecting Serum Soluble fms Like Tyrosine Kinase-1 Based on Biotin-avidin System Timeresolved Fluorescence Immunoassay[J].Journal of Modern Laboratory Medicine,2025,40(01):186.[doi:10.3969/j.issn.1671-7414.2025.02.035]

备注/Memo

备注/Memo:
作者简介：陈龙（1978-），男，本科，副主任检验技师，主要从事临床生化和免疫学检验，E-mail：52837797@qq.com。
通讯作者：郑详武（1982-），男，本科，副主任检验技师，主要从事临床生化检验，E-mail：1065689897@qq.com。
更新日期/Last Update: 2024-01-15